Indikationsspezifische Kosten-Nutzen-Bewertung auf Grundlage eines sozialen Gesundheitsindexes [PDF]
, 2010 Dieser Beitrag entwickelt einen Vorschlag zur indikationsspezifischen Kosten-Nutzen-Bewertung. Zentrales Konzept ist ein sozialer Gesundheitsindex, der die Leistung des Gesundheitswesens misst. Er berücksichtigt nicht nur das Niveau der Gesundheit in der
Kifmann, Mathias
core +1 more source
BMC Health Services Research, 2018 Background The AGREE II instrument is the most commonly used guideline appraisal tool. It includes 23 appraisal criteria (items) organized within six domains.
Wiebke Hoffmann-Eßer +5 more
doaj +1 more source
Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data. [PDF]
PLoS Medicine, 2013 BACKGROUND: Access to unpublished clinical study reports (CSRs) is currently being discussed as a means to allow unbiased evaluation of clinical research.
Beate Wieseler +7 more
doaj +1 more source
Q-SEA - a tool for quality assessment of ethics analyses conducted as part of health technology assessments [PDF]
, 2017 Introduction: Assessment of ethics issues is an important part of health technology assessments (HTA). However, in terms of existence of quality assessment tools, ethics for HTA is methodologically under-developed in comparison to other areas of HTA ...
Bakke Lysdahl, Kristin +5 more
core +3 more sources
Estimation of input costs for a Markov model in a German health economic evaluation of newer antidepressants [PDF]
, 2018 Background: Estimating input costs for Markov models in health economic evaluations requires health state-specific costing. This is a challenge in mental illnesses such as depression, as interventions are not clearly related to health states.
Danner, Marion +10 more
core +1 more source
Limitations of the incidence density ratio as approximation of the hazard ratio
Trials, 2019 Background Incidence density ratios (IDRs) are frequently used to account for varying follow-up times when comparing the risks of adverse events in two treatment groups.
Ralf Bender, Lars Beckmann
doaj +1 more source
Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries [PDF]
, 2017 Although health technology assessment (HTA) systems base their decision making process either on economic evaluations or comparative clinical benefit assessment, a central aim of recent approaches to value measurement, including value based assessment ...
Angelis, Aris +2 more
core +1 more source
Study on impact analysis of policy options for strengthened EU cooperation on Health Technology Assessment (HTA): annexes [PDF]
, 2017 The study’s overall aim was to support the Impact Assessment process of the EC and inform this process by generating data and evidence. In doing so, it provides inputs for analysing the impact of the current situation (baseline scenario) as well as ...
core +1 more source
Zwischen Konsistenz und Flexibilität
Monitor Versorgungsforschung, 2023 Basierend auf den Vorgaben des SGB V bildet Evidenzbasierte Medizin (EbM) die Grundlage für die Arbeit des Gemeinsamen Bundesausschusses (G-BA) sowie des Instituts für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) bei deren medizinischen ...
Hans-Holger Bleß
doaj +1 more source
Cost recommendation under uncertainty in IQWiG’s efficiency frontier framework [PDF]
, 2016 Background: The National Institute for Quality and Efficiency in Health Care (IQWiG) employs an efficiency frontier (EF) framework to facilitate setting maximum reimbursable prices for new interventions.
Al, Maiwenn J. +3 more
core +2 more sources